Adjuvant chemotherapy outcomes of node negative, T1a, T1b, T1c hormone receptor-negative HER2-positive breast cancer patients

被引：0
|
作者：
Paul, Anu
Shi, Runhua
Peddi, Prakash
Burton, Gary
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2761
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2761
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer
    Fasano, Genevieve A.
    Bayard, Solange
    Chen, Yalei
    Varella, Leticia
    Cigler, Tessa
    Bensenhaver, Jessica
    Simmons, Rache
    Swistel, Alexander
    Marti, Jennifer
    Moore, Anne
    Andreopoulou, Eleni
    Ng, John
    Brandmaier, Andrew
    Formenti, Silvia
    Ali, Haythem
    Davis, Melissa
    Newman, Lisa
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 192 (01) : 163 - 173
  • [2] Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer
    Genevieve A. Fasano
    Solange Bayard
    Yalei Chen
    Leticia Varella
    Tessa Cigler
    Jessica Bensenhaver
    Rache Simmons
    Alexander Swistel
    Jennifer Marti
    Anne Moore
    Eleni Andreopoulou
    John Ng
    Andrew Brandmaier
    Silvia Formenti
    Haythem Ali
    Melissa Davis
    Lisa Newman
    Breast Cancer Research and Treatment, 2022, 192 : 163 - 173
  • [3] The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer
    Johnson, Kai C. C.
    Ni, Ai
    Quiroga, Dionisia
    Pariser, Ashley C.
    Sudheendra, Preeti K.
    Williams, Nicole O.
    Sardesai, Sagar D.
    Cherian, Mathew
    Stover, Daniel G.
    Gatti-Mays, Margaret
    Ramaswamy, Bhuvaneswari
    Lustberg, Maryam
    Jhawar, Sachin
    Skoracki, Roman
    Wesolowski, Robert
    NPJ BREAST CANCER, 2024, 10 (01)
  • [4] Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer
    Carbajal-Ochoa, Walter
    Bravo-Solarte, Daniela C.
    Bernal, Ana M.
    Anampa, Jesus D.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (02) : 257 - 269
  • [5] Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer
    Walter Carbajal-Ochoa
    Daniela C. Bravo-Solarte
    Ana M. Bernal
    Jesus D. Anampa
    Breast Cancer Research and Treatment, 2024, 203 : 257 - 269
  • [6] T1b with ER negative, HER2-positive, and node-negative breast cancer patients might get benefit from adjuvant chemotherapy
    Altundag, Kadri
    JOURNAL OF BUON, 2020, 25 (05): : 2529 - 2530
  • [7] The survival benefit of anti-HER2 treatment in the management of small (T1mic, T1a, T1b, T1c), node-negative HER2+breast cancer.
    Johnson, Kai Conrad Cecil
    Ni, Ai
    Grimm, Michael
    Sardesai, Sagar D.
    Stover, Daniel G.
    Cherian, Mathew Amprayil
    Gatti-Mays, Margaret Elena
    Pariser, Ashley
    Sudheendra, Preeti Khetarpal
    Williams, Nicole Olivia
    VanDeusen, Jeffrey Bryan
    Ramaswamy, Bhuvaneswari
    Wesolowski, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Prognostic value of adjuvant chemotherapy for hormone receptor-negative T1a and T1bN0M0 breast cancer patients
    Liu, Yaxiong
    Li, Honghui
    Li, Jinsong
    Wei, Changlong
    Zeng, Jinsheng
    Tian, Qiuhong
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [9] Comparison of Survival Outcomes in Node-Negative T1a and T1b High-risk Breast Cancer Treated with and without Adjuvant Chemotherapy
    Carlson, K. A.
    Thompson, C. K.
    Siegel, E. L.
    Kim, S.
    Bao, J. J.
    Amersi, F.
    Giuliano, A.
    Chung, A.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S98 - S98
  • [10] Cause-specific and all-cause mortality of HER2-positive, node-negative, T1a and T1b breast cancers
    Chew, H. K.
    Brown, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345